New research has shed light on how hyperpigmentation occurs. Experts break down what you need to know in this article.
Whitney J. Palmer
In a recent analysis, researchers examined whether results from a lesion diagnostic assay remained accurate after 12 months. The findings could alter how dermatologists approach future melanoma diagnosis in clinic.
Researchers recently examined a non-invasive test that, if additional studies can confirm, may directly affect future patient care for patients at risk for non-melanoma skin cancer.
With the high incidence of psoriasis and psoriatic arthritis among patients who are obese, it’s important for dermatologists to address weight and weight management. But, having that conversation is not always easy. Dr. Soltani-Arabshahi offers tips to help you talk to your psoriasis patients about their weight.
Data shows obesity is prevalent among patients with psoriasis and psoriatic arthritis, but the exact role weight plays in contributing to psoriatic disease and its severity is still unknown. At a minimum, industry experts agree that addressing obesity can be vital in treating psoriatic disease.
In psoriasis, many therapies offer roughly the same level of care, but that doesn’t mean any patient will respond well to any therapy. According to Mark Lebwohl, M.D., physicians should consider each treatment option in light of a patient's specific comorbidities.
Why do biologics lose efficacy over time? This physician discusses factors dermatologists should consider when they see this issue in their patients.
New consensus conclusions are important, because managing acquired macular pigmentation is a new frontier in dermatology. The article defines terminology and notes the primary feature common to macular pigmentation conditions.
Researchers recently discussed laser and IPLS options for a variety of pigmentary conditions, and provided their recommendations for each one in this review published in European Academy of Dermatology and Venerelogy.
Silymarin, derived from milk thistle, could offer the same level of treatment efficacy for melasma with more benefits for patients than the most widely-used therapy, hydroquinone.